683 Capital Management LLC purchased a new stake in InfuSystem Holdings, Inc. (NYSE:INFU – Free Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 100,465 shares of the company’s stock, valued at approximately $901,000.
Other institutional investors also recently modified their holdings of the company. Quarry LP bought a new position in shares of InfuSystem in the fourth quarter valued at $31,000. Raymond James Financial Inc. bought a new position in shares of InfuSystem in the second quarter valued at $33,000. LPL Financial LLC bought a new position in shares of InfuSystem in the fourth quarter valued at $92,000. GK Wealth Management LLC bought a new position in shares of InfuSystem in the fourth quarter valued at $95,000. Finally, Jane Street Group LLC acquired a new stake in InfuSystem during the 1st quarter valued at $96,000. Institutional investors own 71.13% of the company’s stock.
InfuSystem Price Performance
Shares of NYSE:INFU opened at $8.75 on Thursday. The company’s fifty day moving average is $9.47 and its two-hundred day moving average is $9.07. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. InfuSystem Holdings, Inc. has a 12-month low of $5.38 and a 12-month high of $11.04. The company has a market cap of $176.59 million, a P/E ratio of 145.86 and a beta of 1.43.
Insider Buying and Selling at InfuSystem
In other news, Director Paul Andrew Gendron bought 5,000 shares of the business’s stock in a transaction on Friday, May 8th. The shares were bought at an average cost of $8.88 per share, with a total value of $44,400.00. Following the purchase, the director directly owned 70,000 shares in the company, valued at $621,600. This trade represents a 7.69% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Barry G. Steele bought 7,000 shares of the business’s stock in a transaction on Friday, May 8th. The shares were purchased at an average cost of $8.71 per share, for a total transaction of $60,970.00. Following the completion of the purchase, the chief financial officer owned 96,590 shares in the company, valued at approximately $841,298.90. This trade represents a 7.81% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders have acquired 15,000 shares of company stock worth $131,490. Company insiders own 10.80% of the company’s stock.
Analysts Set New Price Targets
Separately, Roth Mkm reissued a “buy” rating and set a $15.00 target price (up from $14.00) on shares of InfuSystem in a research note on Tuesday, February 24th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, InfuSystem has a consensus rating of “Moderate Buy” and an average price target of $15.00.
Read Our Latest Analysis on InfuSystem
About InfuSystem
InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.
In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.
See Also
- Five stocks we like better than InfuSystem
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding INFU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InfuSystem Holdings, Inc. (NYSE:INFU – Free Report).
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.
